Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Camberwell, Victoria, Australia
SEC filing record 1 source field available
Fiscal year end
30 June
Propanc Biopharma, Inc. has filed 432 SEC EDGAR filings since 23 Jun 2011

SEC filing history

Showing 51-75 of 432 matching filings.

Per page
25
Current page
3
CORRESP

CORRESP filing

Filing date
24 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-282886

S-1/A filing

Filing date
25 Apr 2025
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-282886

S-1/A filing

Filing date
08 Apr 2025
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-282886

S-1/A filing

Filing date
02 Apr 2025
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-282886

S-1/A filing

Filing date
31 Mar 2025
Reporting date
Not listed
Next action
Verify source filing
10-Q File 000-54878

10-Q filing

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
10-Q File 000-54878

10-Q filing

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
UPLOAD File 333-282886

UPLOAD filing

Filing date
06 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-54878

10-K filing

Filing date
30 Sep 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .